D.E. Shaw & Co’s Veradermics Inc MANE Stock Holding History

D.E. Shaw & Co’s Portfolio MANE Stock Details MANE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.48M	Buy	+134,219	New	+$6.77M	0.01%	1781

Other funds holding MANE

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

D.E. Shaw & Co's MANE Position: Q1 2026 in Review

D.E. Shaw & Co opened a new position in Veradermics Inc (MANE) in Q1 2026: 134,219 shares worth $8.48M. The stake represents 0.01% of the portfolio and ranks #1781 among its holdings.

81 funds tracked by Wall St. Rank hold MANE as of Q1 2026.

D.E. Shaw & Co held 134,219 shares of Veradermics Inc worth $8.48M as of Q1 2026.
Veradermics Inc was a new D.E. Shaw & Co position in Q1 2026.
Veradermics Inc made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1781 holding.
81 funds tracked by Wall St. Rank held Veradermics Inc as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.